+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

CSF prolactin determination in patients following operation for pituitary tumor



CSF prolactin determination in patients following operation for pituitary tumor



Surgical Neurology 14(5): 387-391



Serial cerebrospinal fluid (CSF) and plasma prolactin concentrations were determined from patients during prolactin stimulatory testing with thyrotropin-releasing hormone or during pneumoencephalographic stress. Six patients had been operated on for suprasellar extension of pituitary tumor and one had been irradiated for suprasellar extension of a pituitary tumor. Prior to testing, four patients had had no clinical evidence of tumor recurrence and 3 patients had had tumor recurrence. One of the recurrent tumors had again extended into a suprasellar location. Basal CSF prolactin was undetectable in all patients who had had no recurrence. In 3 of the 4 patients without recurrence, however, prolactin became detectable in CSF during stimulatory testing. CSF prolactin values also increased during stimulatory testing in the patient with suprasellar recurrence of the tumor. A basal CSF-to-plasma prolactin ratio was 0.1 or less in all patients without recurrence. In the 2 patients with recurrence but without suprasellar extension, the CSF-to-plasma prolactin ratio was 0.18 or less. The patient with suprasellar recurrence had a strikingly elevated CSF-to-plasma prolactin ratio of 1.1. Thus, an increase of CSF prolactin during stimulatory testing does not necessarily indicate suprasellar recurrence of a pituitary tumor. However, an elevated CSF-to-plasma prolactin ratio appears to remain a valid indicator of suprasellar extension despite prior pituitary surgery.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 042429347

Download citation: RISBibTeXText

PMID: 6255621


Related references

A case report of pituitary tumor presenting as Forbes-Albright syndrome: determination of pituitary prolactin content. Endocrinologia Japonica 14(2): 95-100, 1967

Effects of pituitary tumor on hypothalamic catecholamines prolactin inhibiting activity pituitary prolactin and serum luteinizing hormone. Federation Proceedings: 556, 1978

Factors in predicting outcome from operation in patients with prolactin-secreting pituitary adenomas. Neurosurgery 13(6): 634-641, 1983

Comparison of pituitary tissue prolactin content in normo prolactinemic vs hyper prolactinemic pituitary tumor patients. Clinical Research:, 1979

Catecholamines and pituitary function. 2. Prolactin response to different dopamine doses in normal cycling women and patients with prolactin-secreting pituitary tumors, both before and after endogenous catecholamine synthesis inhibition. Hormone and Metabolic Research 16(12): 658-662, 1984

Lower prolactin levels during cabergoline treatment are associated to tumor shrinkage in prolactin secreting pituitary adenoma. Hormone and Metabolic Research 46(13): 939-942, 2015

Studies of prolactin receptors and the possible proliferative role of prolactin and other pituitary factors in human breast tumor cells. Leung, Bd. . Hormonal Regulation Of Mammary Tumors, Vol. 2. Peptide And Other Hormones. Xvi 283p. Eden Press, Inc: Montreal, Quebec, Canada; St Albans, Vt., Usa; Mtp Press Ltd: Lancaster, England. Illus. P63-76, 1982

Determination of serum prolactin by a specific radio immunoassay in patients with pituitary tumors. Bollettino Societa Italiana Biologia Sperimentale 50(21): (1975) 1853-1856, 1974

Restoration of pituitary prolactin synthesis and release by the administration of morphine to rats bearing a transplanted prolactin-secreting tumor. Neuroendocrinology 33(2): 101-104, 1981

Prolactin of apparent large molecular size: the major immunoactive prolactin component in plasma of a patient with a pituitary tumor. Journal of Clinical Endocrinology and Metabolism 38(4): 714-717, 1974

Differential determination of pituitary prolactin and prolactin-like substances by tissue fat analysis in the pigeon crop test. Nihon Naibunpi Gakkai Zasshi 41(7): 900-911, 1965

Localization Of Prolactin In Rat Pituitary And In A Transplantable Mammotropic Pituitary Tumor Using Fluorescent Antibody. Journal of Histochemistry and Cytochemistry 13: 182-190, 1965

An FSH and prolactin-secreting pituitary tumor: pituitary dynamics and testicular histology. Journal of Clinical Endocrinology and Metabolism 44(2): 248-253, 1977

Effect of antiestrogens on pituitary prolactin production in normal and pituitary tumor-bearing rats. Neuroendocrinology 30(6): 389-395, 1980

The application of fluorescent antibody technique to the localization of endogenous prolactin in normal pituitary tissue and in a tumor of the pituitary. Jour Histo Chem Cytochem 12(1): 16, 1964